Mathias M. Müller

809 total citations
33 papers, 599 citations indexed

About

Mathias M. Müller is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mathias M. Müller has authored 33 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mathias M. Müller's work include SARS-CoV-2 detection and testing (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Mathias M. Müller is often cited by papers focused on SARS-CoV-2 detection and testing (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Mathias M. Müller collaborates with scholars based in Austria, France and Netherlands. Mathias M. Müller's co-authors include Claudia Vidotto, Karl M. Stuhlmeier, Johanna Atamaniuk, Harald Tschan, Norbert Bachl, Ernst Wolner, Michael Grimm, Christoph Buchta, Margit Cichna‐Markl and P. Markl and has published in prestigious journals such as Clinical Chemistry, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

Mathias M. Müller

33 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathias M. Müller Austria 14 171 101 97 77 77 33 599
Hasmukh Patel United States 10 298 1.7× 245 2.4× 68 0.7× 63 0.8× 179 2.3× 24 842
Julie Bellière France 16 228 1.3× 166 1.6× 76 0.8× 21 0.3× 76 1.0× 47 782
Lucas Van Aelst Belgium 14 209 1.2× 204 2.0× 43 0.4× 373 4.8× 109 1.4× 52 756
David Frame United States 16 87 0.5× 116 1.1× 135 1.4× 32 0.4× 94 1.2× 56 873
Anna Pezzotta Italy 19 247 1.4× 131 1.3× 112 1.2× 103 1.3× 73 0.9× 30 961
Pierre‐André Jarrot France 9 190 1.1× 70 0.7× 218 2.2× 53 0.7× 71 0.9× 32 783
Zbigniew Lewandowski Poland 17 294 1.7× 395 3.9× 65 0.7× 69 0.9× 390 5.1× 98 1.1k
Saleem Haj‐Yahia United Kingdom 16 79 0.5× 299 3.0× 29 0.3× 193 2.5× 44 0.6× 36 774
Antigoni Chaidaroglou Greece 16 184 1.1× 84 0.8× 41 0.4× 220 2.9× 101 1.3× 34 727
Gustavo Martínez-Mier Mexico 12 78 0.5× 255 2.5× 58 0.6× 25 0.3× 85 1.1× 82 569

Countries citing papers authored by Mathias M. Müller

Since Specialization
Citations

This map shows the geographic impact of Mathias M. Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias M. Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias M. Müller more than expected).

Fields of papers citing papers by Mathias M. Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias M. Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias M. Müller. The network helps show where Mathias M. Müller may publish in the future.

Co-authorship network of co-authors of Mathias M. Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias M. Müller. A scholar is included among the top collaborators of Mathias M. Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias M. Müller. Mathias M. Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchta, Christoph, Stephan W. Aberle, Irene Görzer, et al.. (2024). External quality assessments for SARS-CoV-2 genome detection in Austria. Wiener klinische Wochenschrift. 136(15-16). 429–438. 1 indexed citations
2.
Buchta, Christoph, Heinz Zeichhardt, Stephan W. Aberle, et al.. (2023). Design of external quality assessment schemes and definition of the roles of their providers in future epidemics. The Lancet Microbe. 4(7). e552–e562. 6 indexed citations
3.
Buchta, Christoph, Lisa Weidner, Mathias M. Müller, et al.. (2023). Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage. Clinical Chemistry and Laboratory Medicine (CCLM). 61(7). 1349–1358. 6 indexed citations
4.
Buchta, Christoph, Wolfgang Huf, Vincent Delatour, et al.. (2022). Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments. Journal of Clinical Virology. 158. 105352–105352. 5 indexed citations
5.
Buchta, Christoph, Wim Coucke, Wolfgang R. Mayr, Mathias M. Müller, & Günther F. Körmöczi. (2019). To Win the Battle, First Know Your Enemy: Error Rates in Immunohematology External Quality Assessment Results. Transfusion Medicine and Hemotherapy. 47(1). 80–87. 1 indexed citations
6.
Buchta, Christoph, Wim Coucke, Wolfgang R. Mayr, et al.. (2018). Evidence for the positive impact of ISO 9001 and ISO 15189 quality systems on laboratory performance – evaluation of immunohaematology external quality assessment results during 19 years in Austria. Clinical Chemistry and Laboratory Medicine (CCLM). 56(12). 2039–2046. 10 indexed citations
7.
Thue, Geir, Éva Ajzner, Andrea R. Horvath, et al.. (2012). Interpretation and management of INR results: A case history based survey in 13 countries. Thrombosis Research. 130(3). 309–315. 13 indexed citations
8.
Müller, Mathias M.. (2010). Quality and diagnostic perspectives in laboratory diagnostics. Biochemia Medica. 144–146. 5 indexed citations
9.
Bieglmayer, Christian, W. Büchinger, Manuela Födinger, et al.. (2008). Labordiagnostischer Leitfaden zur Abklärung von Funktionsstörungen und Erkrankungen der Schilddrüse. Wiener klinische Wochenschrift. 120(11-12). 370–382. 2 indexed citations
10.
Griesmacher, Andrea, et al.. (2006). Guanosine-5′-Triphosphate Increases in Red Blood Cells of Heart Transplant Recipients Treated with Mycophenolate Mofetil. Kluwer Academic Publishers eBooks. 486. 139–143. 5 indexed citations
11.
Hopfinger, Georg, Günther Stockhammer, Alireza Karimi, et al.. (2002). FACS analysis—a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid. Clinica Chimica Acta. 317(1-2). 101–107. 23 indexed citations
12.
13.
14.
Weigel, Günter, Andrea Griesmacher, Gernot Seebacher, et al.. (2000). Adhesion Molecule Behavior during Rejection and Infection Episodes after Heart Transplantation. Clinical Chemistry and Laboratory Medicine (CCLM). 38(5). 403–408. 11 indexed citations
15.
Müller, Mathias M., et al.. (2000). In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. Clinica Chimica Acta. 300(1-2). 23–28. 23 indexed citations
16.
Müller, Mathias M., et al.. (2000). Markers of Endothelial Dysfunction. Clinical Chemistry and Laboratory Medicine (CCLM). 38(2). 77–85. 47 indexed citations
17.
Müller, Mathias M., et al.. (1999). Health care system and laboratory medicine in Austria: present status and future perspectives. Clinica Chimica Acta. 290(1). 37–55. 3 indexed citations
18.
Grimm, Michael, et al.. (1992). Endothelial cell lining of bioprosthetic heart valve materials. Journal of Thoracic and Cardiovascular Surgery. 104(3). 763–769. 28 indexed citations
19.
Grimm, Michael, et al.. (1992). Improved Biocompatibility of Bioprosthetic Heart Valves by L-Glutamic Acid Treatment. Journal of Cardiac Surgery. 7(1). 58–64. 30 indexed citations
20.
Grabenwöger, Martin, Michael Grimm, A Moritz, et al.. (1992). Endothelial Cell Lining of Bioprosthetic Heart Valve Material. Journal of Cardiac Surgery. 7(1). 79–84. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hasmukh Patel Breakdown of academic impact, for papers by Julie Bellière Breakdown of academic impact, for papers by Lucas Van Aelst Breakdown of academic impact, for papers by David Frame Breakdown of academic impact, for papers by Anna Pezzotta Breakdown of academic impact, for papers by Pierre‐André Jarrot Breakdown of academic impact, for papers by Zbigniew Lewandowski Breakdown of academic impact, for papers by Saleem Haj‐Yahia Breakdown of academic impact, for papers by Antigoni Chaidaroglou Breakdown of academic impact, for papers by Gustavo Martínez-Mier
Rankless by CCL
2026